A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats

A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats
复制标题

细胞凋亡在脂多糖(LPS)诱导的 D-半乳糖胺(D-GalN)致敏大鼠非致死性肝损伤中的作用

DOI:
10.1007/s10620-007-9994-y
复制
发表时间:
2008-05-01
影响因子:
3.1
通讯作者:
Sun, Sui-Lin
Sun, Sui-Lin
中科院分区:
医学3区
文献类型:
--
作者:
Liu, Liang-Ming;Zhang, Ji-Xiang;Sun, Sui-Lin

文献摘要

被引文献

相似文献

脂多糖(LPS)与急性肝损伤的病理学有关,当与D-氨基半乳糖(D-GalN)同时给药时,可诱导致死性肝衰竭。目前,低剂量LPS/D-GalN激发后的非致死性肝衰竭(临床意义的肝损伤)尚未完全了解。我们在这里报告我们的调查后,非致死剂量的LPS/D-GalN肝损伤的影响和细胞凋亡在这种疾病中的作用。血清谷丙转氨酶(ALT)、谷草转氨酶(AST)和总胆红素(TBIL)在注射LPS/D-GalN后6 h即开始升高,24 h达高峰,48 h持续高水平。在注射后24和48 h发现肝脏外观异常。6 h开始出现肝细胞死亡、炎性细胞浸润和出血等肝损伤的组织学改变,24 h和48 h明显加重。非致死剂量的LPS/D-GalN攻击可显著诱导细胞凋亡,末端转移酶dUTP缺口末端标记(TUNEL)检测显示,24 h和48 h处理组大鼠的凋亡指数(AI)约为70%。炎性细胞因子IL-1 β的mRNA水平在6小时显著升高,并在24和48小时维持高水平;然而,TNF-α水平在6、24和48小时处理的大鼠的肝组织中是正常的。损伤基因一氧化氮合酶(NOS)mRNA表达在LPS/D-GalN刺激早期即被诱导,6 h达高峰,随后呈阶梯状逐渐下降;相反地,肝细胞凋亡诱导基因p53 mRNA在注射后早期(6 h)没有高表达,但在肝细胞凋亡高峰期(24 h)出现高表达并维持该水平直至晚期(48 h)。LPS/D-GalN刺激24 h后,caspase-3、-8、-9和-12被激活。这些结果表明,低剂量LPS与D-GalN联合攻击可诱导非致死性但显著的肝衰竭,其主要形态学特征是肝细胞凋亡,这可能与诱导型NOS(注射后早期)和p53基因(在中期和晚期)的高表达有关,并且至少有三种凋亡途径参与发病机制。
Lipopolysaccharide (LPS) is implicated in the pathology of acute liver injury and can induce lethal liver failure when simultaneously administered with D-galactosamine (D-GalN). At the present time, nonlethal liver failure, the liver injury of clinical implication, is incompletely understood following challenge by low-dose LPS/D-GalN. We report here our investigation of the effects of liver injury following a nonlethal dose LPS/D-GalN and the role of apoptosis in this disorder. Blood biochemistry indexes, including those of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL), had risen by 6 h post-LPS/D-GalN injection, reached a peak at 24 h and sustained high levels at 48 h. An abnormal liver appearance was found at 24 and 48 h post-injection. Histopathological changes of hepatic injuries accompanied by hepatocellular death, inflammatory infiltration and hemorrhage began to appear at 6 h and were markedly aggravated at 24 and 48 h. Cell apoptosis was significantly induced by the nonlethal dose LPS/D-GalN challenge, and the apoptotic indexes (AIs) in 24 h-and 48 h- treated rats were approximately 70%, as estimated by the terminal transferase dUTP nick end labeling (TUNEL) assay. The mRNA levels of the inflammatory cytokine IL-1 beta rose markedly at 6 h and maintained high levels at 24 and 48 h; however, TNF-alpha a levels were normal in the liver tissues of 6-, 24- and 48- h-treated rats. mRNA expression of the damage gene nitric oxide synthase (NOS) was also induced early by the LPS/D-GalN challenge, reaching a peak at 6 h, then gradually decreasing in a stepwise manner; conversely, high expression levels of the apoptosis-inducing gene p53 mRNA were not found in the early post-injection period ( 6 h) but emerged in the crest-time of liver apoptosis (24 h) and were maintained at this level until the late stage (48 h). We also observed that in 24 h-treated rats, caspase-3,-8, -9 and -12 were markedly activated by LPS/D-GalN challenge. These results suggest that a challenge with low-dose LPS in conjunction with D-GalN can induce nonlethal but marked liver failure, the main morphological feature of which is hepatic apoptosis, which may be associated with a high expression of inducible (i) NOS (early post-injection period) and p53 genes (in the mid and late stages) and at least three apoptosis pathways participate in the pathogenesis.